First-in-class implants for bone regeneration surgery after a bone, ligament or tendon injury

Project description

Disruptive implants regenerate bone after surgery

Every year 1.6 million people in Europe require orthopaedic surgery after bone, ligament or tendon injuries. Current implant materials produce imperfect healing outcomes but NORAKER's technology was adapted for knee ligament regeneration and validated for potential interventions in bone, tendon and ligament injuries. NORAKER's bio-absorbable composite implants can recreate native-like bone structure with no inflammation or pain and very low re-operational risk. The EU-funded REBOOT project will introduce and validate these new first-in-class implants to achieve full healing after orthopaedic surgeries. This involves scale-up of the bio-composite implant for industrial production, supporting the transition towards a truly regenerative orthopaedic surgery.

Fields of science

• medical and health sciences › clinical medicine › surgery
• engineering and technology › materials engineering › composites › biocomposites
• natural sciences › chemical sciences › polymer sciences
• medical and health sciences › clinical medicine › orthopaedics
• medical and health sciences › medical biotechnology › implants

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-2

Funding Scheme

SME-2 - SME instrument phase 2

Coordinator

NORAKER

Net EU contribution

€ 2 481 500,00

Address

60 Avenue Rockefeller
69008 Lyon
France

Region

Auvergne-Rhône-Alpes › Rhône-Alpes › Rhône

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Other funding

€ 1 063 500,00